Epstein-Barr Virus and Marrow Transplantation Recipients

  • Hilaire J. Meuwissen
  • David T. Purtilo


We focus on the role of Epstein-Barr virus (EBV) as an agent potentially causing acute infectious complications in bone marrow transplant patients (MTP). Secondly we consider EBV as a possible contributor to the lymphoid malignancies developing in these patients. We limit our discussion to marrow transplants performed with sibling donors who are matched at the major histocompatibility (MHC) locus with the recipient. Patients receiving marrow not matched at the major histocompatibility locus (MHC) seldom survive for more than a few months.


Marrow Transplantation Primary Immunodeficiency Infectious Mononucleosis Ataxia Telangiectasia Primary Immunodeficiency Disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Reisner, Y., Kapoor, N., Kirkpatrick, D. et al. Transplantation for acute leukemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet, i:327, 1981.CrossRefGoogle Scholar
  2. 2.
    Reinherz, E.L., Geha, R., Rappeport, J.M et al. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc. Natl. Acad. Sci., 79:1982.Google Scholar
  3. 3.
    Gale, R.P. Progress in bone marrow transplantation in man. Surv. Immunol. Res., 1:40, 1982.PubMedGoogle Scholar
  4. 4.
    Bach, F.H., Albertini, R.H., Anderson, J.L., Joo, P., and Bortin, M.M. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet, ii:1364, 1968.CrossRefGoogle Scholar
  5. 5.
    Gatti, R.A., Meuwissen, H.J., Allen, H.D., Hong, R., and Good, R.A. Immunologic reconstitution of sex-linked lymphopenic immunologic deficiency. Lancet, ii:l366, 1968.Google Scholar
  6. 6.
    Kapoor, N., Kirkpatrick, D., Blaese, R.M. et al. Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. Blood, 57:692, 1981.PubMedGoogle Scholar
  7. 7.
    Thomas, E.D., Fefer, A., Buckner, C.D., and Storb, R. Current status of bone marrow transplantation for aplastic anemia and acute leukemia. A critical review. Blood, 49:671, 1977.PubMedGoogle Scholar
  8. 8.
    Buckley, R.H. Transplantation. In: E.R. Stiehm and V.A. Fulginiti (eds.), Immunologic disorders in infants and children. pp. 795. Philadelphia: WB Saunders, 1980.Google Scholar
  9. 9.
    Joncas, J., Lapointe, N., Gervais, F., and Leyritz, M. Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibodies in ataxia telangiectasia. J. Immunol., 119:1857, 1977.PubMedGoogle Scholar
  10. 10.
    Berkel, A.I. et al. Epstein-Barr virus (EBV) carrying lymphoma in a patient with ataxia telangiectasia (AT) and review of immune responses to EBV in AT patients. Submitted for publication.Google Scholar
  11. 11.
    Purtilo, D.T., Bechtold, T., Harada, S., Yetz, J., Rogers, G., and Meuwissin, H.J. Epstein-Barr virus in a family with Wiskott-Aldrich syndrome. J Ped., in press.Google Scholar
  12. 12.
    Hoyer, J.R., Cooper, M.D., Gabrielson, A.E., and Good, R.A. Lymphopenic forms of congenital immunologic deficiency diseases. Medicine, 47:201, 1968.PubMedCrossRefGoogle Scholar
  13. 13.
    Filipovich, A.H, Spector, B.D, and Kersey, J. Immunodeficiency in humans as a risk factor in the development of malignancy. Prevent Med., 9:252, 1980.CrossRefGoogle Scholar
  14. 14.
    Frizzera, G., Rosai, J., Dehner, L.P., Spector, B.D., and Kersey, J.H. Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer, 46:692, 1980.PubMedCrossRefGoogle Scholar
  15. 15.
    Saemundsen, A.K. Epstein-Barr virus-carrying lymphoma in a patient with ataxia-telangiectasia. Brit. Med. J., 282:425, 1981.CrossRefGoogle Scholar
  16. 16.
    Graze, P.R. and Gale, R.P. Chronic graft-versus-host disease: a syndrome of disordered immunity. Am. J. Med., 66:611, 1979.PubMedCrossRefGoogle Scholar
  17. 17.
    Howard, R.J., Miller, J., and Najarian, J.S. Cytomegalo-virus-induced immune suppression. II. Cell-mediated immunity. Clin. Exp. Immunol., 18:119, 1974.PubMedGoogle Scholar
  18. 18.
    Witherspoon, R.P., Storb, R., Ochs, H.D. et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time post-transplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood, 58:360, 1981.PubMedGoogle Scholar
  19. 19.
    Lum, L.G., Seigneuret, M.C., Storb, R.F., Witherspoon, R.P., and Thomas, E.D. In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graf t-versus-host disease. Blood, 58:431, 1981.PubMedGoogle Scholar
  20. 20.
    Atkinson, K., Farewell, V., Storb, R. et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood, 60:714, 1982.PubMedGoogle Scholar
  21. 21.
    Radl, J., Dooren, L.J., Eijsvoogel, V.P., Van Went, J.J., Hijmans, W. An immunological study during post-transplantation follow-up of a case of severe combined immunodeficiency. Clin. Exp. Immunol., 10:367, 1972.PubMedGoogle Scholar
  22. 22.
    Clift, R.A., Buckner, C.D., Fefer, A. et al. Infectious complications of marrow transplantation. Transplant« Proc., 6:389, 1974.PubMedGoogle Scholar
  23. 23.
    Lange, B., Henle, W., Meyers, J.D., Yang, L.C., August, C., Koch, P., Arbeter, A., and Henle, G. Epstein-Barr virus related serology in marrow transplant recipients. Int. J. Cancer, 26:151, 1980.PubMedCrossRefGoogle Scholar
  24. 24.
    Sullivan, J.L., Wallen, W.C., and Johnson, F.L. Epstein-Barr virus infection following bone marrow transplantation. Int. J. Cancer, 22:132, 1978.PubMedCrossRefGoogle Scholar
  25. 25.
    Data obtained from the Statistical Center of the International Bone Marrow Transplant Registry. The analysis has not been reviewed or approved by the Advisory Committee of the Registry.Google Scholar
  26. 26.
    Gossett, T.C., Gale, R.P., and Fleischman, H. Immunoblastic sarcoma in donor cells after bone-marrow transplantation. N. Engl. J. Med., 300:904, 1979.PubMedCrossRefGoogle Scholar
  27. 27.
    Schubach, W.H., Hackman, R., Neiman, P.E., Miller, G., and Thomas, E.D. A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood, 60:180, 1982.PubMedGoogle Scholar
  28. 28.
    Dr. Israel Penn (personal communication).Google Scholar
  29. 29.
    Fialkow, P.J., Thoraas, E.D., Bryant, J.E., and Neiman, P.E., Leukaemic transformation of engrafted human marrow cells in vivo. Lancet, i:251, 1971.CrossRefGoogle Scholar
  30. 30.
    Thomas, E.D., Bryant, J.I., Buckner, C.D. et al. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet, i:1310, 1972.CrossRefGoogle Scholar
  31. 31.
    Goh, K. and Kemperer, M.R. In vivo leukemic transformation cytogenetic evidence of in vivo leukemic transformation of engrafter marrow cells. Am. J. Hematol, 2:283, 1977.PubMedCrossRefGoogle Scholar
  32. 32.
    Elfenbeing, G.J., Brogaonkar, D.S., Bias, W.B. et al. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood, 52:627, 1978.Google Scholar
  33. 33.
    Newburger, P.E., Latt, S.A., Pesando, J.M. et al. Leukemia relapse in donor cells after allogeneic bone marrow transplantation. N. Engl. J. Med., 304;712, 1981.PubMedCrossRefGoogle Scholar
  34. 34.
    Buckley, R.H. Transplantation. In: E.R. Stiehm and V.A. Fulginiti (eds.), Immunologic Disorders in Infants and Children. pp. 776–804. Philadelphia: WB Saunders, 1980.Google Scholar
  35. 35.
    Dr. C. Dean Buckner (personal communication)Google Scholar
  36. 36.
    Hanto, D.W., Frizzera, G., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Saeraundsen, A.K., Klein, G., Simmons, R.L., and Najarian, J.S. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res., 41:4253, 1982.Google Scholar
  37. 37.
    Reece, E.R., Gartner, J.G., Seeraayer, T.A., Joncas, J.H., and Pagano, J.S. Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res., 41:4243, 1982.Google Scholar
  38. 38.
    Walford, R.L. Increased incidence of lymphoma after injections of mice with cells differing at weak histocompatibility loci. Science, 152:78, 1966.PubMedCrossRefGoogle Scholar
  39. 39.
    Louie, S. and Schwatz, R.S. Immunodeficiency and the pathogenesis of lymphoma and leukemia. Sem. Hematol., 15:117, 1978.Google Scholar
  40. 40.
    Floersheim, G.L., Nassenstein, D., and Torhorst, J. Growth of human tumors in mice after short-term immunosuppression with procarbazine, cyclophosphamide, and antilymphocyte serum. Transplantation, 30:275, 1980.PubMedCrossRefGoogle Scholar
  41. 41.
    Herra, G.A. and Head, D.R. Histiocytic lymphoma arising at the site of injection of antilymphocytic globulin: necropsy follow-up of previously reported case. Milit. Med., 146:652, 1981.Google Scholar
  42. 42.
    Matas, A.J., Simmons, R.L., and Najarian, J.S. Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients. Lancet, i:1277, 1975.CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Hilaire J. Meuwissen
    • 1
  • David T. Purtilo
    • 2
  1. 1.Center for Laboratories ResearchBirth Defects InstituteAlbanyUSA
  2. 2.Department of Pathology & LaboratoryOmahaUSA

Personalised recommendations